FundFollowerFundFollower
Super FundsTop AssetsActivityPortfoliosArticlesAbout

Get the FundFollower newsletter

13F-season insights and notable moves. No spam — unsubscribe anytime.

© 2025 FundFollower. All rights reserved.

Data sourced from public SEC filings.

HomeContact UsSuper FundsTop AssetsAbout

Crinetics Pharmaceuticals Inc.

CRNX

1 institutional investors and hedge funds own CRNX, holding 8,989,098 shares worth $336.4M (latest 13F filings).

Advanced Chart

Who owns Crinetics Pharmaceuticals Inc. stock?

Institutional holders of CRNX — largest position first.

Super Fund
Position
Shares
Curr. Value
Port. %
Activity
Farallon Capital ManagementEquity
8,989,098
$336,372,047
1.99%
+7.81%

Ownership Statistics

Total Shares Held: 8,989,098
Total Value Reported: $336,372,047
Average Allocation per Portfolio 1.99%
Largest Single Portfolio Allocation: 1.99%
Largest Shareholder: Farallon Capital Management
Change in Total Shares Held (Q on Q): +651,000
Percentage Change in Shares Held (Q on Q): 7.81%
Number of Super Fund Holders: 1
Number of New Holders (Q on Q): 0
Number of Funds with Additions (Q on Q): 1
Number of Funds with Reductions (Q on Q): 0
Number of Funds Fully Divested (Q on Q): 0
Number of Funds with No Change (Q on Q): 0

Ownership Distribution

Loading chart…

Ownership History

Loading chart…

Company Profile

Fundamental Data